Global POC Infectious Diseases Market Size, Status and Forecast 2021-2027

Global POC Infectious Diseases Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global POC Infectious Diseases Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Flu
1.2.3 Adenovirus
1.2.4 Malaria
1.2.5 Streptococcal Bacteremia
1.2.6 Tuberculosis (TB)
1.2.7 Occult Blood
1.2.8 HIV
1.3 Market by Application
1.3.1 Global POC Infectious Diseases Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital& Clinics
1.3.3 Clinical Diagnostic Laboratories
1.3.4 Homecare Settings
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global POC Infectious Diseases Market Perspective (2016-2027)
2.2 POC Infectious Diseases Growth Trends by Regions
2.2.1 POC Infectious Diseases Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 POC Infectious Diseases Historic Market Share by Regions (2016-2021)
2.2.3 POC Infectious Diseases Forecasted Market Size by Regions (2022-2027)
2.3 POC Infectious Diseases Industry Dynamic
2.3.1 POC Infectious Diseases Market Trends
2.3.2 POC Infectious Diseases Market Drivers
2.3.3 POC Infectious Diseases Market Challenges
2.3.4 POC Infectious Diseases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top POC Infectious Diseases Players by Revenue
3.1.1 Global Top POC Infectious Diseases Players by Revenue (2016-2021)
3.1.2 Global POC Infectious Diseases Revenue Market Share by Players (2016-2021)
3.2 Global POC Infectious Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by POC Infectious Diseases Revenue
3.4 Global POC Infectious Diseases Market Concentration Ratio
3.4.1 Global POC Infectious Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by POC Infectious Diseases Revenue in 2020
3.5 POC Infectious Diseases Key Players Head office and Area Served
3.6 Key Players POC Infectious Diseases Product Solution and Service
3.7 Date of Enter into POC Infectious Diseases Market
3.8 Mergers & Acquisitions, Expansion Plans
4 POC Infectious Diseases Breakdown Data by Type
4.1 Global POC Infectious Diseases Historic Market Size by Type (2016-2021)
4.2 Global POC Infectious Diseases Forecasted Market Size by Type (2022-2027)
5 POC Infectious Diseases Breakdown Data by Application
5.1 Global POC Infectious Diseases Historic Market Size by Application (2016-2021)
5.2 Global POC Infectious Diseases Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America POC Infectious Diseases Market Size (2016-2027)
6.2 North America POC Infectious Diseases Market Size by Type
6.2.1 North America POC Infectious Diseases Market Size by Type (2016-2021)
6.2.2 North America POC Infectious Diseases Market Size by Type (2022-2027)
6.2.3 North America POC Infectious Diseases Market Size by Type (2016-2027)
6.3 North America POC Infectious Diseases Market Size by Application
6.3.1 North America POC Infectious Diseases Market Size by Application (2016-2021)
6.3.2 North America POC Infectious Diseases Market Size by Application (2022-2027)
6.3.3 North America POC Infectious Diseases Market Size by Application (2016-2027)
6.4 North America POC Infectious Diseases Market Size by Country
6.4.1 North America POC Infectious Diseases Market Size by Country (2016-2021)
6.4.2 North America POC Infectious Diseases Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe POC Infectious Diseases Market Size (2016-2027)
7.2 Europe POC Infectious Diseases Market Size by Type
7.2.1 Europe POC Infectious Diseases Market Size by Type (2016-2021)
7.2.2 Europe POC Infectious Diseases Market Size by Type (2022-2027)
7.2.3 Europe POC Infectious Diseases Market Size by Type (2016-2027)
7.3 Europe POC Infectious Diseases Market Size by Application
7.3.1 Europe POC Infectious Diseases Market Size by Application (2016-2021)
7.3.2 Europe POC Infectious Diseases Market Size by Application (2022-2027)
7.3.3 Europe POC Infectious Diseases Market Size by Application (2016-2027)
7.4 Europe POC Infectious Diseases Market Size by Country
7.4.1 Europe POC Infectious Diseases Market Size by Country (2016-2021)
7.4.2 Europe POC Infectious Diseases Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific POC Infectious Diseases Market Size (2016-2027)
8.2 Asia-Pacific POC Infectious Diseases Market Size by Type
8.2.1 Asia-Pacific POC Infectious Diseases Market Size by Type (2016-2021)
8.2.2 Asia-Pacific POC Infectious Diseases Market Size by Type (2022-2027)
8.2.3 Asia-Pacific POC Infectious Diseases Market Size by Type (2016-2027)
8.3 Asia-Pacific POC Infectious Diseases Market Size by Application
8.3.1 Asia-Pacific POC Infectious Diseases Market Size by Application (2016-2021)
8.3.2 Asia-Pacific POC Infectious Diseases Market Size by Application (2022-2027)
8.3.3 Asia-Pacific POC Infectious Diseases Market Size by Application (2016-2027)
8.4 Asia-Pacific POC Infectious Diseases Market Size by Region
8.4.1 Asia-Pacific POC Infectious Diseases Market Size by Region (2016-2021)
8.4.2 Asia-Pacific POC Infectious Diseases Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America POC Infectious Diseases Market Size (2016-2027)
9.2 Latin America POC Infectious Diseases Market Size by Type
9.2.1 Latin America POC Infectious Diseases Market Size by Type (2016-2021)
9.2.2 Latin America POC Infectious Diseases Market Size by Type (2022-2027)
9.2.3 Latin America POC Infectious Diseases Market Size by Type (2016-2027)
9.3 Latin America POC Infectious Diseases Market Size by Application
9.3.1 Latin America POC Infectious Diseases Market Size by Application (2016-2021)
9.3.2 Latin America POC Infectious Diseases Market Size by Application (2022-2027)
9.3.3 Latin America POC Infectious Diseases Market Size by Application (2016-2027)
9.4 Latin America POC Infectious Diseases Market Size by Country
9.4.1 Latin America POC Infectious Diseases Market Size by Country (2016-2021)
9.4.2 Latin America POC Infectious Diseases Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa POC Infectious Diseases Market Size (2016-2027)
10.2 Middle East & Africa POC Infectious Diseases Market Size by Type
10.2.1 Middle East & Africa POC Infectious Diseases Market Size by Type (2016-2021)
10.2.2 Middle East & Africa POC Infectious Diseases Market Size by Type (2022-2027)
10.2.3 Middle East & Africa POC Infectious Diseases Market Size by Type (2016-2027)
10.3 Middle East & Africa POC Infectious Diseases Market Size by Application
10.3.1 Middle East & Africa POC Infectious Diseases Market Size by Application (2016-2021)
10.3.2 Middle East & Africa POC Infectious Diseases Market Size by Application (2022-2027)
10.3.3 Middle East & Africa POC Infectious Diseases Market Size by Application (2016-2027)
10.4 Middle East & Africa POC Infectious Diseases Market Size by Country
10.4.1 Middle East & Africa POC Infectious Diseases Market Size by Country (2016-2021)
10.4.2 Middle East & Africa POC Infectious Diseases Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott POC Infectious Diseases Introduction
11.1.4 Abbott Revenue in POC Infectious Diseases Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Meridian Bioscience
11.2.1 Meridian Bioscience Company Details
11.2.2 Meridian Bioscience Business Overview
11.2.3 Meridian Bioscience POC Infectious Diseases Introduction
11.2.4 Meridian Bioscience Revenue in POC Infectious Diseases Business (2016-2021)
11.2.5 Meridian Bioscience Recent Development
11.3 Orasure Technologies
11.3.1 Orasure Technologies Company Details
11.3.2 Orasure Technologies Business Overview
11.3.3 Orasure Technologies POC Infectious Diseases Introduction
11.3.4 Orasure Technologies Revenue in POC Infectious Diseases Business (2016-2021)
11.3.5 Orasure Technologies Recent Development
11.4 Trinity Biotech
11.4.1 Trinity Biotech Company Details
11.4.2 Trinity Biotech Business Overview
11.4.3 Trinity Biotech POC Infectious Diseases Introduction
11.4.4 Trinity Biotech Revenue in POC Infectious Diseases Business (2016-2021)
11.4.5 Trinity Biotech Recent Development
11.5 Beckman Coulter/ Danaher
11.5.1 Beckman Coulter/ Danaher Company Details
11.5.2 Beckman Coulter/ Danaher Business Overview
11.5.3 Beckman Coulter/ Danaher POC Infectious Diseases Introduction
11.5.4 Beckman Coulter/ Danaher Revenue in POC Infectious Diseases Business (2016-2021)
11.5.5 Beckman Coulter/ Danaher Recent Development
11.6 Becton Dickinson
11.6.1 Becton Dickinson Company Details
11.6.2 Becton Dickinson Business Overview
11.6.3 Becton Dickinson POC Infectious Diseases Introduction
11.6.4 Becton Dickinson Revenue in POC Infectious Diseases Business (2016-2021)
11.6.5 Becton Dickinson Recent Development
11.7 Biomerieux
11.7.1 Biomerieux Company Details
11.7.2 Biomerieux Business Overview
11.7.3 Biomerieux POC Infectious Diseases Introduction
11.7.4 Biomerieux Revenue in POC Infectious Diseases Business (2016-2021)
11.7.5 Biomerieux Recent Development
11.8 Bio-Rad
11.8.1 Bio-Rad Company Details
11.8.2 Bio-Rad Business Overview
11.8.3 Bio-Rad POC Infectious Diseases Introduction
11.8.4 Bio-Rad Revenue in POC Infectious Diseases Business (2016-2021)
11.8.5 Bio-Rad Recent Development
11.9 Cepheid
11.9.1 Cepheid Company Details
11.9.2 Cepheid Business Overview
11.9.3 Cepheid POC Infectious Diseases Introduction
11.9.4 Cepheid Revenue in POC Infectious Diseases Business (2016-2021)
11.9.5 Cepheid Recent Development
11.10 Diamedix
11.10.1 Diamedix Company Details
11.10.2 Diamedix Business Overview
11.10.3 Diamedix POC Infectious Diseases Introduction
11.10.4 Diamedix Revenue in POC Infectious Diseases Business (2016-2021)
11.10.5 Diamedix Recent Development
11.11 Diasorin
11.11.1 Diasorin Company Details
11.11.2 Diasorin Business Overview
11.11.3 Diasorin POC Infectious Diseases Introduction
11.11.4 Diasorin Revenue in POC Infectious Diseases Business (2016-2021)
11.11.5 Diasorin Recent Development
11.12 Eiken Chemical
11.12.1 Eiken Chemical Company Details
11.12.2 Eiken Chemical Business Overview
11.12.3 Eiken Chemical POC Infectious Diseases Introduction
11.12.4 Eiken Chemical Revenue in POC Infectious Diseases Business (2016-2021)
11.12.5 Eiken Chemical Recent Development
11.13 Enzo Biochem
11.13.1 Enzo Biochem Company Details
11.13.2 Enzo Biochem Business Overview
11.13.3 Enzo Biochem POC Infectious Diseases Introduction
11.13.4 Enzo Biochem Revenue in POC Infectious Diseases Business (2016-2021)
11.13.5 Enzo Biochem Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global POC Infectious Diseases Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Flu
Table 3. Key Players of Adenovirus
Table 4. Key Players of Malaria
Table 5. Key Players of Streptococcal Bacteremia
Table 6. Key Players of Tuberculosis (TB)
Table 7. Key Players of Occult Blood
Table 8. Key Players of HIV
Table 9. Global POC Infectious Diseases Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global POC Infectious Diseases Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global POC Infectious Diseases Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global POC Infectious Diseases Market Share by Regions (2016-2021)
Table 13. Global POC Infectious Diseases Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global POC Infectious Diseases Market Share by Regions (2022-2027)
Table 15. POC Infectious Diseases Market Trends
Table 16. POC Infectious Diseases Market Drivers
Table 17. POC Infectious Diseases Market Challenges
Table 18. POC Infectious Diseases Market Restraints
Table 19. Global POC Infectious Diseases Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global POC Infectious Diseases Market Share by Players (2016-2021)
Table 21. Global Top POC Infectious Diseases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in POC Infectious Diseases as of 2020)
Table 22. Ranking of Global Top POC Infectious Diseases Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by POC Infectious Diseases Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players POC Infectious Diseases Product Solution and Service
Table 26. Date of Enter into POC Infectious Diseases Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global POC Infectious Diseases Market Size by Type (2016-2021) (US$ Million)
Table 29. Global POC Infectious Diseases Revenue Market Share by Type (2016-2021)
Table 30. Global POC Infectious Diseases Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global POC Infectious Diseases Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global POC Infectious Diseases Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global POC Infectious Diseases Revenue Market Share by Application (2016-2021)
Table 34. Global POC Infectious Diseases Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global POC Infectious Diseases Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America POC Infectious Diseases Market Size by Type (2016-2021) (US$ Million)
Table 37. North America POC Infectious Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America POC Infectious Diseases Market Size by Application (2016-2021) (US$ Million)
Table 39. North America POC Infectious Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America POC Infectious Diseases Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America POC Infectious Diseases Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe POC Infectious Diseases Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe POC Infectious Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe POC Infectious Diseases Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe POC Infectious Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe POC Infectious Diseases Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe POC Infectious Diseases Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific POC Infectious Diseases Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific POC Infectious Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific POC Infectious Diseases Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific POC Infectious Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific POC Infectious Diseases Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific POC Infectious Diseases Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America POC Infectious Diseases Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America POC Infectious Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America POC Infectious Diseases Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America POC Infectious Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America POC Infectious Diseases Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America POC Infectious Diseases Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa POC Infectious Diseases Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa POC Infectious Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa POC Infectious Diseases Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa POC Infectious Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa POC Infectious Diseases Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa POC Infectious Diseases Market Size by Country (2022-2027) & (US$ Million)
Table 66. Abbott Company Details
Table 67. Abbott Business Overview
Table 68. Abbott POC Infectious Diseases Product
Table 69. Abbott Revenue in POC Infectious Diseases Business (2016-2021) & (US$ Million)
Table 70. Abbott Recent Development
Table 71. Meridian Bioscience Company Details
Table 72. Meridian Bioscience Business Overview
Table 73. Meridian Bioscience POC Infectious Diseases Product
Table 74. Meridian Bioscience Revenue in POC Infectious Diseases Business (2016-2021) & (US$ Million)
Table 75. Meridian Bioscience Recent Development
Table 76. Orasure Technologies Company Details
Table 77. Orasure Technologies Business Overview
Table 78. Orasure Technologies POC Infectious Diseases Product
Table 79. Orasure Technologies Revenue in POC Infectious Diseases Business (2016-2021) & (US$ Million)
Table 80. Orasure Technologies Recent Development
Table 81. Trinity Biotech Company Details
Table 82. Trinity Biotech Business Overview
Table 83. Trinity Biotech POC Infectious Diseases Product
Table 84. Trinity Biotech Revenue in POC Infectious Diseases Business (2016-2021) & (US$ Million)
Table 85. Trinity Biotech Recent Development
Table 86. Beckman Coulter/ Danaher Company Details
Table 87. Beckman Coulter/ Danaher Business Overview
Table 88. Beckman Coulter/ Danaher POC Infectious Diseases Product
Table 89. Beckman Coulter/ Danaher Revenue in POC Infectious Diseases Business (2016-2021) & (US$ Million)
Table 90. Beckman Coulter/ Danaher Recent Development
Table 91. Becton Dickinson Company Details
Table 92. Becton Dickinson Business Overview
Table 93. Becton Dickinson POC Infectious Diseases Product
Table 94. Becton Dickinson Revenue in POC Infectious Diseases Business (2016-2021) & (US$ Million)
Table 95. Becton Dickinson Recent Development
Table 96. Biomerieux Company Details
Table 97. Biomerieux Business Overview
Table 98. Biomerieux POC Infectious Diseases Product
Table 99. Biomerieux Revenue in POC Infectious Diseases Business (2016-2021) & (US$ Million)
Table 100. Biomerieux Recent Development
Table 101. Bio-Rad Company Details
Table 102. Bio-Rad Business Overview
Table 103. Bio-Rad Revenue in POC Infectious Diseases Business (2016-2021) & (US$ Million)
Table 104. Bio-Rad Recent Development
Table 105. Cepheid Company Details
Table 106. Cepheid Business Overview
Table 107. Cepheid POC Infectious Diseases Product
Table 108. Cepheid Revenue in POC Infectious Diseases Business (2016-2021) & (US$ Million)
Table 109. Cepheid Recent Development
Table 110. Diamedix Company Details
Table 111. Diamedix Business Overview
Table 112. Diamedix POC Infectious Diseases Product
Table 113. Diamedix Revenue in POC Infectious Diseases Business (2016-2021) & (US$ Million)
Table 114. Diamedix Recent Development
Table 115. Diasorin Company Details
Table 116. Diasorin Business Overview
Table 117. Diasorin POC Infectious Diseases Product
Table 118. Diasorin Revenue in POC Infectious Diseases Business (2016-2021) & (US$ Million)
Table 119. Diasorin Recent Development
Table 120. Eiken Chemical Company Details
Table 121. Eiken Chemical Business Overview
Table 122. Eiken Chemical POC Infectious Diseases Product
Table 123. Eiken Chemical Revenue in POC Infectious Diseases Business (2016-2021) & (US$ Million)
Table 124. Eiken Chemical Recent Development
Table 125. Enzo Biochem Company Details
Table 126. Enzo Biochem Business Overview
Table 127. Enzo Biochem POC Infectious Diseases Product
Table 128. Enzo Biochem Revenue in POC Infectious Diseases Business (2016-2021) & (US$ Million)
Table 129. Enzo Biochem Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global POC Infectious Diseases Market Share by Type: 2020 VS 2027
Figure 2. Flu Features
Figure 3. Adenovirus Features
Figure 4. Malaria Features
Figure 5. Streptococcal Bacteremia Features
Figure 6. Tuberculosis (TB) Features
Figure 7. Occult Blood Features
Figure 8. HIV Features
Figure 9. Global POC Infectious Diseases Market Share by Application: 2020 VS 2027
Figure 10. Hospital& Clinics Case Studies
Figure 11. Clinical Diagnostic Laboratories Case Studies
Figure 12. Homecare Settings Case Studies
Figure 13. POC Infectious Diseases Report Years Considered
Figure 14. Global POC Infectious Diseases Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global POC Infectious Diseases Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global POC Infectious Diseases Market Share by Regions: 2020 VS 2027
Figure 17. Global POC Infectious Diseases Market Share by Regions (2022-2027)
Figure 18. Global POC Infectious Diseases Market Share by Players in 2020
Figure 19. Global Top POC Infectious Diseases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in POC Infectious Diseases as of 2020
Figure 20. The Top 10 and 5 Players Market Share by POC Infectious Diseases Revenue in 2020
Figure 21. Global POC Infectious Diseases Revenue Market Share by Type (2016-2021)
Figure 22. Global POC Infectious Diseases Revenue Market Share by Type (2022-2027)
Figure 23. North America POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America POC Infectious Diseases Market Share by Type (2016-2027)
Figure 25. North America POC Infectious Diseases Market Share by Application (2016-2027)
Figure 26. North America POC Infectious Diseases Market Share by Country (2016-2027)
Figure 27. United States POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe POC Infectious Diseases Market Share by Type (2016-2027)
Figure 31. Europe POC Infectious Diseases Market Share by Application (2016-2027)
Figure 32. Europe POC Infectious Diseases Market Share by Country (2016-2027)
Figure 33. Germany POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific POC Infectious Diseases Market Share by Type (2016-2027)
Figure 41. Asia-Pacific POC Infectious Diseases Market Share by Application (2016-2027)
Figure 42. Asia-Pacific POC Infectious Diseases Market Share by Region (2016-2027)
Figure 43. China POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America POC Infectious Diseases Market Share by Type (2016-2027)
Figure 51. Latin America POC Infectious Diseases Market Share by Application (2016-2027)
Figure 52. Latin America POC Infectious Diseases Market Share by Country (2016-2027)
Figure 53. Mexico POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa POC Infectious Diseases Market Share by Type (2016-2027)
Figure 57. Middle East & Africa POC Infectious Diseases Market Share by Application (2016-2027)
Figure 58. Middle East & Africa POC Infectious Diseases Market Share by Country (2016-2027)
Figure 59. Turkey POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Abbott Revenue Growth Rate in POC Infectious Diseases Business (2016-2021)
Figure 63. Meridian Bioscience Revenue Growth Rate in POC Infectious Diseases Business (2016-2021)
Figure 64. Orasure Technologies Revenue Growth Rate in POC Infectious Diseases Business (2016-2021)
Figure 65. Trinity Biotech Revenue Growth Rate in POC Infectious Diseases Business (2016-2021)
Figure 66. Beckman Coulter/ Danaher Revenue Growth Rate in POC Infectious Diseases Business (2016-2021)
Figure 67. Becton Dickinson Revenue Growth Rate in POC Infectious Diseases Business (2016-2021)
Figure 68. Biomerieux Revenue Growth Rate in POC Infectious Diseases Business (2016-2021)
Figure 69. Bio-Rad Revenue Growth Rate in POC Infectious Diseases Business (2016-2021)
Figure 70. Cepheid Revenue Growth Rate in POC Infectious Diseases Business (2016-2021)
Figure 71. Diamedix Revenue Growth Rate in POC Infectious Diseases Business (2016-2021)
Figure 72. Diasorin Revenue Growth Rate in POC Infectious Diseases Business (2016-2021)
Figure 73. Eiken Chemical Revenue Growth Rate in POC Infectious Diseases Business (2016-2021)
Figure 74. Enzo Biochem Revenue Growth Rate in POC Infectious Diseases Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs